drugset
drugset / Trial / NCT05972902

Dydrogesterone, Cetrorelix Acetate and Triptorelin in Intra Cytoplasmic Sperm Injection Outcomes

NCT05972902 ↗

Phase 3 Unknown 387 enrolled Beni-Suef University
RandomizedParallel-groupOpen-labelTreatment

Summary

To compare the effects of Duphaston compared to GnRH agonist and antagonist on the prevention of premature LH surge and quality of retrieved oocytes and embryos in women undergoing intra-cytoplasmic sperm injection.

Timeline

Start
2023-07-15
Primary completion
2023-12-31
Completion
2023-12-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator Cetrorelix Other / unclassified 0.25 mg Subcutaneous
Subject Dydrogesterone Other / unclassified 10 mg Oral
Comparator Triptorelin Other / unclassified 0.1 mg Subcutaneous
Comparator Triptorelin Other / unclassified 0.2 mg Subcutaneous

Indications

No indication recorded.